# AbCellera Biologics Inc.: Form 8-K, filed Jun 21, 2022

- Company: [AbCellera Biologics Inc.](/companies/abcl.md) (CIK 1703057)
- Form: 8-K
- Filed: 2022-06-21
- Accepted by EDGAR: Jun 21, 2022, 12:28 ET
- Period: 2022-06-15
- Accession: 0001564590-22-023707
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1703057/000156459022023707/abcl-8k_20220615.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703057/000156459022023707/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703057/000156459022023707/abcl-8k_20220615.htm

Filed Jun 21, 2022.
Source: SEC EDGAR, the filing index for accession 0001564590-22-023707. Last ingested by Listed: Nov 15, 2026, 01:06 ET. No prices; not investment advice.
